1. Home
  2. CGNT vs ALT Comparison

CGNT vs ALT Comparison

Compare CGNT & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGNT
  • ALT
  • Stock Information
  • Founded
  • CGNT 2020
  • ALT 1997
  • Country
  • CGNT Israel
  • ALT United States
  • Employees
  • CGNT N/A
  • ALT N/A
  • Industry
  • CGNT Computer Software: Prepackaged Software
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CGNT Technology
  • ALT Health Care
  • Exchange
  • CGNT Nasdaq
  • ALT Nasdaq
  • Market Cap
  • CGNT 465.2M
  • ALT 457.0M
  • IPO Year
  • CGNT N/A
  • ALT N/A
  • Fundamental
  • Price
  • CGNT $7.01
  • ALT $6.79
  • Analyst Decision
  • CGNT Hold
  • ALT Buy
  • Analyst Count
  • CGNT 3
  • ALT 6
  • Target Price
  • CGNT $8.25
  • ALT $18.80
  • AVG Volume (30 Days)
  • CGNT 242.0K
  • ALT 2.0M
  • Earning Date
  • CGNT 12-11-2024
  • ALT 11-05-2024
  • Dividend Yield
  • CGNT N/A
  • ALT N/A
  • EPS Growth
  • CGNT N/A
  • ALT N/A
  • EPS
  • CGNT N/A
  • ALT N/A
  • Revenue
  • CGNT $330,212,000.00
  • ALT $409,000.00
  • Revenue This Year
  • CGNT $12.30
  • ALT N/A
  • Revenue Next Year
  • CGNT $7.28
  • ALT N/A
  • P/E Ratio
  • CGNT N/A
  • ALT N/A
  • Revenue Growth
  • CGNT 12.00
  • ALT N/A
  • 52 Week Low
  • CGNT $4.00
  • ALT $2.09
  • 52 Week High
  • CGNT $8.70
  • ALT $14.84
  • Technical
  • Relative Strength Index (RSI)
  • CGNT 55.70
  • ALT 53.27
  • Support Level
  • CGNT $6.47
  • ALT $5.92
  • Resistance Level
  • CGNT $7.06
  • ALT $7.24
  • Average True Range (ATR)
  • CGNT 0.21
  • ALT 0.37
  • MACD
  • CGNT 0.07
  • ALT 0.06
  • Stochastic Oscillator
  • CGNT 88.73
  • ALT 67.39

About CGNT Cognyte Software Ltd.

Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: